| NCT ID | NCT07112924 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Impulse Dynamics |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,500 participants |
| Start Date | 2025-11-01 |
| Primary Completion | 2035-08-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,500 participants in total. It began in 2025-11-01 with a primary completion date of 2035-08-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The registry has been designed to evaluate the long-term safety and efficacy of CCM therapy in a real-world setting.
Eligibility Criteria
Inclusion Criteria: * Patients who have /will be implanted with Impulse Dynamics CCM technologies (e.g. CCM or CCM-D when available) as determined by investigators * Willing and able to provide informed consent, including for use of data for research purposes (e.g. publication, sub-studies/sub-analyses) Exclusion Criteria: * Noncompliant patients (e.g. for follow-up visits, medication, etc.) as determined by investigators. * Subjects with a mechanical tricuspid valve
Contact & Investigator
Anthony Hong
STUDY DIRECTOR
Impulse Dynamics
Frequently Asked Questions
Who can join the NCT07112924 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07112924 currently recruiting?
Yes, NCT07112924 is actively recruiting participants. Contact the research team at kvanwygerden@impulsedynamics.com for enrollment information.
Where is the NCT07112924 trial being conducted?
This trial is being conducted at Mesa, United States, Phoenix, United States, Phoenix, United States, Surprise, United States and 11 additional locations.
Who is sponsoring the NCT07112924 clinical trial?
NCT07112924 is sponsored by Impulse Dynamics. The principal investigator is Anthony Hong at Impulse Dynamics. The trial plans to enroll 5,500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.